BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37792677)

  • 21. Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells.
    Lu R; Zhao G; Yang Y; Jiang Z; Cai J; Hu H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819864311. PubMed ID: 31405336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Integrative Analysis Reveals the Association of
    Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-224 aggrevates tumor growth and progression by targeting mTOR in gastric cancer.
    Zhang Y; Li CF; Ma LJ; Ding M; Zhang B
    Int J Oncol; 2016 Sep; 49(3):1068-80. PubMed ID: 27315344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
    Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
    Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Jiang Y; Han Q; Zhao H; Zhang J
    J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5/PI3K/AKT/mTOR pathway in gastric cancer.
    Su P; Jiang L; Zhang Y; Yu T; Kang W; Liu Y; Yu J
    Cancer Cell Int; 2022 Sep; 22(1):290. PubMed ID: 36151545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma.
    Bao L; Li X
    Mol Cell Biochem; 2019 Oct; 460(1-2):67-79. PubMed ID: 31218569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy suppresses isoprenaline-induced M2 macrophage polarization via the ROS/ERK and mTOR signaling pathway.
    Shan M; Qin J; Jin F; Han X; Guan H; Li X; Zhang J; Zhang H; Wang Y
    Free Radic Biol Med; 2017 Sep; 110():432-443. PubMed ID: 28647611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.
    Yang J; Xing Z
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway in gastric cancer.
    Zhang Y; Wu Y; Su X
    Front Biosci (Landmark Ed); 2021 Aug; 26(8):322-334. PubMed ID: 34455762
    [No Abstract]   [Full Text] [Related]  

  • 31. Exosomal microRNA-588 from M2 polarized macrophages contributes to cisplatin resistance of gastric cancer cells.
    Cui HY; Rong JS; Chen J; Guo J; Zhu JQ; Ruan M; Zuo RR; Zhang SS; Qi JM; Zhang BH
    World J Gastroenterol; 2021 Sep; 27(36):6079-6092. PubMed ID: 34629821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shenmai Injection Supresses Glycolysis and Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant A549/DDP Cells via the AKT-mTOR-c-Myc Signaling Pathway.
    Sun Y; Chen Y; Xu M; Liu C; Shang H; Wang C
    Biomed Res Int; 2020; 2020():9243681. PubMed ID: 32685545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Validation of a Metabolism-Related Prognostic Signature Associated with M2 Macrophage Infiltration in Gastric Cancer.
    Liu Y; Zheng H; Gu AM; Li Y; Wang T; Li C; Gu Y; Lin J; Ding X
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astragalus mongholicus Bunge-Curcuma aromatica Salisb. suppresses growth and metastasis of colorectal cancer cells by inhibiting M2 macrophage polarization via a Sp1/ZFAS1/miR-153-3p/CCR5 regulatory axis.
    Gu J; Sun R; Tang D; Liu F; Chang X; Wang Q
    Cell Biol Toxicol; 2022 Aug; 38(4):679-697. PubMed ID: 35072892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y; Fei Z; Zhu R
    Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K/AKT/mTOR pathway.
    Wang YY; Zhou YQ; Xie JX; Zhang X; Wang SC; Li Q; Hu LP; Jiang SH; Yi SQ; Xu J; Cao H; Zhao EH; Li J
    Cell Oncol (Dordr); 2023 Oct; 46(5):1429-1444. PubMed ID: 37249744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA‑495 regulates human gastric cancer cell apoptosis and migration through Akt and mTOR signaling.
    Wang J; Feng W; Dong Y; Mao X; Guo F; Luo F
    Oncol Rep; 2018 Dec; 40(6):3654-3662. PubMed ID: 30272336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircSOD2 polarizes macrophages towards the M1 phenotype to alleviate cisplatin resistance in gastric cancer cells by targeting the miR-1296/STAT1 axis.
    Qu B; Liu J; Peng Z; Xiao Z; Li S; Wu J; Li S; Luo J
    Gene; 2023 Dec; 887():147733. PubMed ID: 37625563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leishmania infection activates host mTOR for its survival by M2 macrophage polarization.
    Kumar A; Das S; Mandal A; Verma S; Abhishek K; Kumar A; Kumar V; Ghosh AK; Das P
    Parasite Immunol; 2018 Nov; 40(11):e12586. PubMed ID: 30187512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxic lung cancer cell-derived exosomal miR-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting IRF1.
    Jin J; Yu G
    World J Surg Oncol; 2022 Jul; 20(1):241. PubMed ID: 35897096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.